| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 820.9 | 705.9 |
| Profit before tax | 34.2 | 65.2 |
| Net income | 17.3 | -117.1 |
| EPS (diluted, $ a share) | $0.02 | $-0.17 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +16.3% |
|---|
10-Q filed with the SEC, NYSE: DOC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Healthpeak Properties, Inc.: key numbers
- Share price
- $19.46Close, Nov 17
- Market cap
- $13.4B
- Shares outstanding
- 689.54MLatest SEC cover page
- Sector
- Real Estate & Construction
- Industry
- Real Estate Investment TrustsSIC 6798
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Healthpeak Properties, Inc.
All →Healthpeak Properties EVP and Treasurer Ankit B. Patadia Sells $127K of Stock
Ankit B. Patadia, EVP and Treasurer, sold 6,115 shares of Healthpeak Properties, Inc. at $20.78 a share, worth $127K in total on Nov 9, 2026. Shares held after the trade: 2,838 (-68.3%).
- Value
- $127K
- Shares
- 6,115
- Price
- $20.78
- Role
- EVP and Treasurer
- Holding change
- -68.3%
- Trade date
- Nov 9, 2026
Healthpeak Properties Earnings Call: Key Takeaways
Healthpeak Properties raised FFO guidance for the third time, driven by strong life science occupancy gains and record senior housing performance via its Janice Living platform.
- Call
- Nov 3, 2026, 10:00 AM ET
Healthpeak Properties Financial Results
Healthpeak Properties reported third quarter 2026 financial results, including net income of $0.02 per share and FFO as Adjusted of $0.44 per share. The company increased its full-year 2026 earnings guidance and highlighted strong leasing activity in its Outpatient Medical and Lab segments, alongside significant acquisition activity in its majority-owned Janus Living subsidiary.